Kåre Inge Birkeland

  • Professor
  • +47 23034587
 

Publications 2019

Arora S, Ofstad AP, Ulimoen GR, Birkeland KI, Endresen K, Gullestad L, Johansen OE (2019)
Asymptomatic coronary artery disease in a Norwegian cohort with type 2 diabetes: a prospective angiographic study with intravascular ultrasound evaluation
Cardiovasc Diabetol, 18 (1), 26
DOI 10.1186/s12933-019-0832-2, PubMed 30851727

Borgeraas H, Hjelmesæth J, Birkeland KI, Fatima F, Grimnes JO, Gulseth HL, Halvorsen E, Hertel JK, Hillestad TOW, Johnson LK, Karlsen TI, Kolotkin RL, Kvan NP, Lindberg M, Lorentzen J, Nordstrand N, Sandbu R, Seeberg KA, Seip B, Svanevik M, Valderhaug TG, Hofsø D (2019)
Single-centre, triple-blinded, randomised, 1-year, parallel-group, superiority study to compare the effects of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes and β-cell function in subjects with morbid obesity: a protocol for the Obesity surgery in Tønsberg (Oseberg) study
BMJ Open, 9 (6), e024573
DOI 10.1136/bmjopen-2018-024573, PubMed 31167860

Elvebakk O, Tronstad C, Birkeland KI, Jenssen TG, Bjørgaas MR, Frøslie KF, Godang K, Kalvøy H, Martinsen ØG, Gulseth HL (2019)
Author Correction: Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia
Sci Rep, 9 (1), 6347
DOI 10.1038/s41598-019-42218-6, PubMed 30988313

Elvebakk O, Tronstad C, Birkeland KI, Jenssen TG, Bjørgaas MR, Gulseth HL, Kalvøy H, Høgetveit JO, Martinsen ØG (2019)
A multiparameter model for non-invasive detection of hypoglycemia
Physiol Meas, 40 (8), 085004
DOI 10.1088/1361-6579/ab3676, PubMed 31357185

Gulseth HL, Gjelstad IMF, Tiereny AC, McCarthy D, Lovegrove JA, Defoort C, Blaak EE, Lopez-Miranda J, Dembinska-Kiec A, Risérus U, Roche HM, Drevon CA, Birkeland KI (2019)
Effects of dietary fat on insulin secretion in subjects with the metabolic syndrome
Eur J Endocrinol, 180 (5), 321-328
DOI 10.1530/EJE-19-0022, PubMed 30893645

Haugen AJ, Langberg NE, Dahle DO, Pihlstrøm H, Birkeland KI, Reisaeter A, Midtvedt K, Hartmann A, Holdaas H, Mjøen G (2019)
Long-term risk for kidney donors with hypertension at donation - a retrospective cohort study
Transpl Int, 32 (9), 960-964
DOI 10.1111/tri.13443, PubMed 30983060

Lee S, Kolset SO, Birkeland KI, Drevon CA, Reine TM (2019)
Acute exercise increases syndecan-1 and -4 serum concentrations
Glycoconj J, 36 (2), 113-125
DOI 10.1007/s10719-019-09869-z, PubMed 30949875

Lee S, Norheim F, Langleite TM, Gulseth HL, Birkeland KI, Drevon CA (2019)
Effects of long-term exercise on plasma adipokine levels and inflammation-related gene expression in subcutaneous adipose tissue in sedentary dysglycaemic, overweight men and sedentary normoglycaemic men of healthy weight
Diabetologia, 62 (6), 1048-1064
DOI 10.1007/s00125-019-4866-5, PubMed 31011777

Ofstad AP, Sommer C, Birkeland KI, Bjørgaas MR, Gran JM, Gulseth HL, Johansen OE (2019)
Comparison of the associations between non-traditional and traditional indices of adiposity and cardiovascular mortality: an observational study of one million person-years of follow-up
Int J Obes (Lond), 43 (5), 1082-1092
DOI 10.1038/s41366-019-0353-9, PubMed 30926954

Vedal TSJ, Steen NE, Birkeland KI, Dieset I, Reponen EJ, Laskemoen JF, Rødevand L, Melle I, Andreassen OA, Molden E, Jönsson EG (2019)
Adipokine levels are associated with insulin resistance in antipsychotics users independently of BMI
Psychoneuroendocrinology, 103, 87-95
DOI 10.1016/j.psyneuen.2019.01.001, PubMed 30659986

Publications 2018

Baerug A, Sletner L, Laake P, Fretheim A, Løland BF, Waage CW, Birkeland KI, Jenum AK (2018)
Recent gestational diabetes was associated with mothers stopping predominant breastfeeding earlier in a multi-ethnic population
Acta Paediatr, 107 (6), 1028-1035
DOI 10.1111/apa.14274, PubMed 29432660

Birkeland K (2018)
THE MASTERY OF LIFE WITH DIABETES Type I
Tidsskr. Nor. Laegeforen., 138 (18), 1767

Birkeland KI, Bodegard J, Norhammar A, Kuiper JG, Georgiado E, Beekman-Hendriks WL, Thuresson M, Pignot M, Herings RMC, Kooy A (2018)
How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study
Diabetes Obes Metab, 21 (4), 968-974
DOI 10.1111/dom.13612, PubMed 30537226

Birkeland KI, Grill V, Wium C, McQueen MJ, Lopez-Jaramillo P, Lee SF, Gerstein HC (2018)
The association of basal insulin treatment versus standard care with outcomes in anti-GAD positive and negative subjects: A post-hoc analysis of the ORIGIN trial
Diabetes Obes Metab, 21 (2), 429-433
DOI 10.1111/dom.13528, PubMed 30203580

Cavender MA, Norhammar A, Birkeland KI, Jørgensen ME, Wilding JP, Khunti K, Fu AZ, Bodegård J, Blak BT, Wittbrodt E, Thuresson M, Fenici P, Hammar N, Kosiborod M, CVD-REAL Investigators and Study Group (2018)
SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL
J Am Coll Cardiol, 71 (22), 2497-2506
DOI 10.1016/j.jacc.2018.01.085, PubMed 29852973

Davies TT, Graue M, Igland J, Tell GS, Birkeland KI, Peyrot M, Haltbakk J (2018)
Diabetes prevalence among older people receiving care at home: associations with symptoms, health status and psychological well-being
Diabet Med, 36 (1), 96-104
DOI 10.1111/dme.13790, PubMed 30062788

Eggemoen ÅR, Waage CW, Sletner L, Gulseth HL, Birkeland KI, Jenum AK (2018)
Vitamin D, Gestational Diabetes, and Measures of Glucose Metabolism in a Population-Based Multiethnic Cohort
J Diabetes Res, 2018, 8939235
DOI 10.1155/2018/8939235, PubMed 29850611

Elvebakk O, Tronstad C, Birkeland KI, Jenssen TG, Bjørgaas MR, Frøslie KF, Godang K, Kalvøy H, Martinsen ØG, Gulseth HL (2018)
Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia
Sci Rep, 8 (1), 14722
DOI 10.1038/s41598-018-33189-1, PubMed 30283093

Heier M, Ofstad AP, Borja MS, Brunborg C, Endresen K, Gullestad L, Birkeland KI, Johansen OE, Oda MN (2018)
High-density lipoprotein function is associated with atherosclerotic burden and cardiovascular outcomes in type 2 diabetes
Atherosclerosis, 282, 183-187
DOI 10.1016/j.atherosclerosis.2018.07.005, PubMed 30017177

Kosiborod M, Birkeland KI, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Jørgensen ME, Wittbrodt ET, Thuresson M, Bodegård J, Hammar N, Fenici P, CVD-REAL Investigators and Study Group (2018)
Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study
Diabetes Obes Metab, 20 (8), 1983-1987
DOI 10.1111/dom.13299, PubMed 29569378

Kosiborod M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Birkeland KI, Jørgensen ME, Thuresson M, Arya N, Bodegård J, Hammar N, Fenici P, CVD-REAL Investigators and Study Group (2018)
Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)"
Circulation, 137 (9), 989-991
DOI 10.1161/CIRCULATIONAHA.117.031847, PubMed 29483180

Lee S, Norheim F, Gulseth HL, Langleite TM, Aker A, Gundersen TE, Holen T, Birkeland KI, Drevon CA (2018)
Skeletal muscle phosphatidylcholine and phosphatidylethanolamine respond to exercise and influence insulin sensitivity in men
Sci Rep, 8 (1), 6531
DOI 10.1038/s41598-018-24976-x, PubMed 29695812

Lee S, Norheim F, Gulseth HL, Langleite TM, Aker A, Gundersen TE, Holen T, Birkeland KI, Drevon CA (2018)
Author Correction: Skeletal muscle phosphatidylcholine and phosphatidylethanolamine respond to exercise and influence insulin sensitivity in men
Sci Rep, 8 (1), 7885
DOI 10.1038/s41598-018-26061-9, PubMed 29760520

Lee S, Olsen T, Vinknes KJ, Refsum H, Gulseth HL, Birkeland KI, Drevon CA (2018)
Plasma Sulphur-Containing Amino Acids, Physical Exercise and Insulin Sensitivity in Overweight Dysglycemic and Normal Weight Normoglycemic Men
Nutrients, 11 (1)
DOI 10.3390/nu11010010, PubMed 30577516

Moen GH, LeBlanc M, Sommer C, Prasad RB, Lekva T, Normann KR, Qvigstad E, Groop L, Birkeland KI, Evans DM, Frøslie KF (2018)
Genetic determinants of glucose levels in pregnancy: genetic risk scores analysis and GWAS in the Norwegian STORK cohort
Eur J Endocrinol, 179 (6), 363-372
DOI 10.1530/EJE-18-0478, PubMed 30324795

Moen GH, Qvigstad E, Birkeland KI, Evans DM, Sommer C (2018)
Are serum concentrations of vitamin B-12 causally related to cardiometabolic risk factors and disease? A Mendelian randomization study
Am J Clin Nutr, 108 (2), 398-404
DOI 10.1093/ajcn/nqy101, PubMed 29982347

Nordheim E, Birkeland KI, Åsberg A, Hartmann A, Horneland R, Jenssen T (2018)
Preserved insulin secretion and kidney function in recipients with functional pancreas grafts 1 year after transplantation: a single-center prospective observational study
Eur J Endocrinol, 179 (4), 251-259
DOI 10.1530/EJE-18-0360, PubMed 30299895

Persson F, Bodegard J, Lahtela JT, Nyström T, Jørgensen ME, Jensen ML, Gulseth HL, Thuresson M, Hoti F, Nathanson D, Norhammar A, Birkeland KI, Eriksson JG, Eriksson JW (2018)
Different patterns of second-line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study
Endocrinol Diabetes Metab, 1 (4), e00036
DOI 10.1002/edm2.36, PubMed 30815564

Riiser A, Solbraa A, Jenum AK, Birkeland KI, Andersen LB (2018)
Cycling and walking for transport and their associations with diabetes and risk factors for cardiovascular disease
J. Transp. Health, 11, 193-201

Ruiz PLD, Stene LC, Bakken IJ, Håberg SE, Birkeland KI, Gulseth HL (2018)
Decreasing incidence of pharmacologically and non-pharmacologically treated type 2 diabetes in Norway: a nationwide study
Diabetologia, 61 (11), 2310-2318
DOI 10.1007/s00125-018-4681-4, PubMed 29995214

Sommer C, Lee S, Gulseth HL, Jensen J, Drevon CA, Birkeland KI (2018)
Soluble Leptin Receptor Predicts Insulin Sensitivity and Correlates With Upregulation of Metabolic Pathways in Men
J Clin Endocrinol Metab, 103 (3), 1024-1032
DOI 10.1210/jc.2017-02126, PubMed 29300960

Thuresson M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Birkeland KI, Jørgensen ME, Wittbrodt E, Hammar N, Fenici P, Kosiborod M, CVD-REAL Investigators and Study Group (2018)
Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10
Diabetes Care, 41 (6), e106-e108
DOI 10.2337/dc18-0338, PubMed 29784708

Tronstad C, Elvebakk O, Staal OM, Kalvøy H, Høgetveit JO, Jenssen TG, Birkeland KI, Martinsen ØG (2018)
Non-invasive prediction of blood glucose trends during hypoglycemia
Anal Chim Acta, 1052, 37-48
DOI 10.1016/j.aca.2018.12.009, PubMed 30685040

Vedal TSJ, Steen NE, Birkeland KI, Dieset I, Reponen EJ, Laskemoen JF, Rødevand L, Melle I, Andreassen OA, Molden E, Jönsson EG (2018)
Response: Are thyroid abnormalities only related to antipsychotic treatment in patients with severe mental disorders?
J Psychiatr Res, 117, 150
DOI 10.1016/j.jpsychires.2018.11.012, PubMed 30454945

Vedal TSJ, Steen NE, Birkeland KI, Dieset I, Reponen EJ, Laskemoen JF, Rødevand L, Melle I, Andreassen OA, Molden E, Jönsson EG (2018)
Free thyroxine and thyroid-stimulating hormone in severe mental disorders: A naturalistic study with focus on antipsychotic medication
J Psychiatr Res, 106, 74-81
DOI 10.1016/j.jpsychires.2018.09.014, PubMed 30292780

Publications 2017

Birkeland KI (2017)
Populærvitenskapelig om testosteron
Tidsskr Nor Laegeforen, 137 (18)
DOI 10.4045/tidsskr.17.0517, PubMed 28972339

Birkeland KI (2017)
Anti-diabetes is just a part of good diabetes treatment!
Tidsskr. Nor. Laegeforen., 137 (18), 1395-1396

Birkeland KI (2017)
TESTOSTERONE
Tidsskr. Nor. Laegeforen., 137 (18), 1453

Birkeland KI (2017)
Antidiabetika er bare en del av god diabetesbehandling!
Tidsskr Nor Laegeforen, 137 (18)
DOI 10.4045/tidsskr.17.0774, PubMed 28972323

Birkeland KI, Jørgensen ME, Carstensen B, Persson F, Gulseth HL, Thuresson M, Fenici P, Nathanson D, Nyström T, Eriksson JW, Bodegård J, Norhammar A (2017)
Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis
Lancet Diabetes Endocrinol, 5 (9), 709-717
DOI 10.1016/S2213-8587(17)30258-9, PubMed 28781064

Gulseth HL, Wium C, Angel K, Eriksen EF, Birkeland KI (2017)
Effects of Vitamin D Supplementation on Insulin Sensitivity and Insulin Secretion in Subjects With Type 2 Diabetes and Vitamin D Deficiency: A Randomized Controlled Trial
Diabetes Care, 40 (7), 872-878
DOI 10.2337/dc16-2302, PubMed 28468770

Görgens SW, Benninghoff T, Eckardt K, Springer C, Chadt A, Melior A, Wefers J, Cramer A, Jensen J, Birkeland KI, Drevon CA, Al-Hasani H, Eckel J (2017)
Hypoxia in Combination With Muscle Contraction Improves Insulin Action and Glucose Metabolism in Human Skeletal Muscle via the HIF-1α Pathway
Diabetes, 66 (11), 2800-2807
DOI 10.2337/db16-1488, PubMed 28811274

Jenssen T, Hartmann A, Birkeland KI (2017)
Long-term diabetes complications after pancreas transplantation
Curr Opin Organ Transplant, 22 (4), 382-388
DOI 10.1097/MOT.0000000000000436, PubMed 28598888

Kosiborod M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Birkeland KI, Jørgensen ME, Thuresson M, Arya N, Bodegård J, Hammar N, Fenici P, CVD-REAL Investigators and Study Group* (2017)
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)
Circulation, 136 (3), 249-259
DOI 10.1161/CIRCULATIONAHA.117.029190, PubMed 28522450

Lee S, Norheim F, Gulseth HL, Langleite TM, Kolnes KJ, Tangen DS, Stadheim HK, Gilfillan GD, Holen T, Birkeland KI, Jensen J, Drevon CA (2017)
Interaction between plasma fetuin-A and free fatty acids predicts changes in insulin sensitivity in response to long-term exercise
Physiol Rep, 5 (5)
DOI 10.14814/phy2.13183, PubMed 28270597

Lund J, Rustan AC, Løvsletten NG, Mudry JM, Langleite TM, Feng YZ, Stensrud C, Brubak MG, Drevon CA, Birkeland KI, Kolnes KJ, Johansen EI, Tangen DS, Stadheim HK, Gulseth HL, Krook A, Kase ET, Jensen J, Thoresen GH (2017)
Exercise in vivo marks human myotubes in vitro: Training-induced increase in lipid metabolism
PLoS One, 12 (4), e0175441
DOI 10.1371/journal.pone.0175441, PubMed 28403174

Moen GH, Sommer C, Prasad RB, Sletner L, Groop L, Qvigstad E, Birkeland KI (2017)
MECHANISMS IN ENDOCRINOLOGY: Epigenetic modifications and gestational diabetes: a systematic review of published literature
Eur J Endocrinol, 176 (5), R247-R267
DOI 10.1530/EJE-16-1017, PubMed 28232369

Ofstad AP, Ulimoen GR, Orvik E, Birkeland KI, Gullestad LL, Fagerland MW, Johansen OE (2017)
Long-term follow-up of a hospital-based, multi-intervention programme in type 2 diabetes mellitus: impact on cardiovascular events and death
J Int Med Res, 45 (5), 1535-1552
DOI 10.1177/0300060517707674, PubMed 28627980

Persson F, Nyström T, Jørgensen ME, Carstensen B, Gulseth HL, Thuresson M, Fenici P, Nathanson D, Eriksson JW, Norhammar A, Bodegard J, Birkeland KI (2017)
Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational study
Diabetes Obes Metab, 20 (2), 344-351
DOI 10.1111/dom.13077, PubMed 28771923

Pourteymour S, Eckardt K, Holen T, Langleite T, Lee S, Jensen J, Birkeland KI, Drevon CA, Hjorth M (2017)
Global mRNA sequencing of human skeletal muscle: Search for novel exercise-regulated myokines
Mol Metab, 6 (4), 352-365
DOI 10.1016/j.molmet.2017.01.007, PubMed 28377874

Pourteymour S, Hjorth M, Lee S, Holen T, Langleite TM, Jensen J, Birkeland KI, Drevon CA, Eckardt K (2017)
Dual specificity phosphatase 5 and 6 are oppositely regulated in human skeletal muscle by acute exercise
Physiol Rep, 5 (19)
DOI 10.14814/phy2.13459, PubMed 28989118

Risstad H, Kristinsson JA, Fagerland MW, le Roux CW, Birkeland KI, Gulseth HL, Thorsby PM, Vincent RP, Engström M, Olbers T, Mala T (2017)
Bile acid profiles over 5 years after gastric bypass and duodenal switch: results from a randomized clinical trial
Surg Obes Relat Dis, 13 (9), 1544-1553
DOI 10.1016/j.soard.2017.05.024, PubMed 28756050

Sletner L, Jenum AK, Yajnik CS, Mørkrid K, Nakstad B, Rognerud-Jensen OH, Birkeland KI, Vangen S (2017)
Fetal growth trajectories in pregnancies of European and South Asian mothers with and without gestational diabetes, a population-based cohort study
PLoS One, 12 (3), e0172946
DOI 10.1371/journal.pone.0172946, PubMed 28253366

Publications 2016

Eggemoen ÅR, Falk RS, Knutsen KV, Lagerløv P, Sletner L, Birkeland KI, Jenum AK (2016)
Vitamin D deficiency and supplementation in pregnancy in a multiethnic population-based cohort
BMC Pregnancy Childbirth, 16, 7
DOI 10.1186/s12884-016-0796-0, PubMed 26785795

Langleite TM, Jensen J, Norheim F, Gulseth HL, Tangen DS, Kolnes KJ, Heck A, Storås T, Grøthe G, Dahl MA, Kielland A, Holen T, Noreng HJ, Stadheim HK, Bjørnerud A, Johansen EI, Nellemann B, Birkeland KI, Drevon CA (2016)
Insulin sensitivity, body composition and adipose depots following 12 w combined endurance and strength training in dysglycemic and normoglycemic sedentary men
Arch Physiol Biochem, 122 (4), 167-179
DOI 10.1080/13813455.2016.1202985, PubMed 27477619

Lee S, Norheim F, Langleite TM, Noreng HJ, Storås TH, Afman LA, Frost G, Bell JD, Thomas EL, Kolnes KJ, Tangen DS, Stadheim HK, Gilfillan GD, Gulseth HL, Birkeland KI, Jensen J, Drevon CA, Holen T, NutriTech Consortium (2016)
Effect of energy restriction and physical exercise intervention on phenotypic flexibility as examined by transcriptomics analyses of mRNA from adipose tissue and whole body magnetic resonance imaging
Physiol Rep, 4 (21)
DOI 10.14814/phy2.13019, PubMed 27821717

Sommer C, Gulseth HL, Jenum AK, Sletner L, Thorsby PM, Birkeland KI (2016)
Soluble Leptin Receptor and Risk of Gestational Diabetes in a Multiethnic Population: A Prospective Cohort Study
J Clin Endocrinol Metab, 101 (11), 4070-4075
DOI 10.1210/jc.2016-2583, PubMed 27537771

Waage C, Jenum AK, Mdala I, Berg JP, Richardsen K, Birkeland K (2016)
Associations between gestational diabetes mellitus and elevated HbA1c early postpartum in a multi-ethnic population
Prim Care Diabetes, 11 (2), 132-139
DOI 10.1016/j.pcd.2016.09.007, PubMed 27771271

Waage CW, Mdala I, Jenum AK, Michelsen TM, Birkeland KI, Sletner L (2016)
Ethnic differences in blood pressure from early pregnancy to postpartum: a Norwegian cohort study
J Hypertens, 34 (6), 1151-9
DOI 10.1097/HJH.0000000000000918, PubMed 27088633

Publications 2015

Birkeland KI (2015)
Hyperglycaemia in pregnancy: still a lot to learn
Lancet Diabetes Endocrinol, 3 (10), 752-3
DOI 10.1016/S2213-8587(15)00282-X, PubMed 26355009

Birkeland KI (2015)
Hypoglycaemia in clinical diabetes
Tidsskr. Nor. Laegeforen., 135 (9), 876

Görgens SW, Hjorth M, Eckardt K, Wichert S, Norheim F, Holen T, Lee S, Langleite T, Birkeland KI, Stadheim HK, Kolnes KJ, Tangen DS, Kolnes AJ, Jensen J, Drevon CA, Eckel J (2015)
The exercise-regulated myokine chitinase-3-like protein 1 stimulates human myocyte proliferation
Acta Physiol (Oxf), 216 (3), 330-45
DOI 10.1111/apha.12579, PubMed 26303257

Hjorth M, Norheim F, Meen AJ, Pourteymour S, Lee S, Holen T, Jensen J, Birkeland KI, Martinov VN, Langleite TM, Eckardt K, Drevon CA, Kolset SO (2015)
The effect of acute and long-term physical activity on extracellular matrix and serglycin in human skeletal muscle
Physiol Rep, 3 (8)
DOI 10.14814/phy2.12473, PubMed 26290530

Hjorth M, Pourteymour S, Görgens SW, Langleite TM, Lee S, Holen T, Gulseth HL, Birkeland KI, Jensen J, Drevon CA, Norheim F (2015)
Myostatin in relation to physical activity and dysglycaemia and its effect on energy metabolism in human skeletal muscle cells
Acta Physiol (Oxf), 217 (1), 45-60
DOI 10.1111/apha.12631, PubMed 26572800

Hofsø D, Birkeland KI, Holst JJ, Bollerslev J, Sandbu R, Røislien J, Hjelmesæth J (2015)
Gastric bypass surgery has a weight-loss independent effect on post-challenge serum glucose levels
Diabetol Metab Syndr, 7, 69
DOI 10.1186/s13098-015-0066-8, PubMed 26300987

Ofstad AP, Urheim S, Dalen H, Orvik E, Birkeland KI, Gullestad L, W Fagerland M, Johansen OE, Aakhus S (2015)
Identification of a definite diabetic cardiomyopathy in type 2 diabetes by comprehensive echocardiographic evaluation: A cross-sectional comparison with non-diabetic weight-matched controls
J Diabetes, 7 (6), 779-90
DOI 10.1111/1753-0407.12239, PubMed 25350248

Pourteymour S, Lee S, Langleite TM, Eckardt K, Hjorth M, Bindesbøll C, Dalen KT, Birkeland KI, Drevon CA, Holen T, Norheim F (2015)
Perilipin 4 in human skeletal muscle: localization and effect of physical activity
Physiol Rep, 3 (8)
DOI 10.14814/phy2.12481, PubMed 26265748

Risstad H, Søvik TT, Engström M, Aasheim ET, Fagerland MW, Olsén MF, Kristinsson JA, le Roux CW, Bøhmer T, Birkeland KI, Mala T, Olbers T (2015)
Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60: a randomized clinical trial
JAMA Surg, 150 (4), 352-61
DOI 10.1001/jamasurg.2014.3579, PubMed 25650964

Sommer C, Jenum AK, Waage CW, Mørkrid K, Sletner L, Birkeland KI (2015)
Ethnic differences in BMI, subcutaneous fat, and serum leptin levels during and after pregnancy and risk of gestational diabetes
Eur J Endocrinol, 172 (6), 649-56
DOI 10.1530/EJE-15-0060, PubMed 25740849

Sommer C, Sletner L, Mørkrid K, Jenum AK, Birkeland KI (2015)
Effects of early pregnancy BMI, mid-gestational weight gain, glucose and lipid levels in pregnancy on offspring's birth weight and subcutaneous fat: a population-based cohort study
BMC Pregnancy Childbirth, 15, 84
DOI 10.1186/s12884-015-0512-5, PubMed 25879215

Waage CW, Falk RS, Sommer C, Mørkrid K, Richardsen KR, Baerug A, Shakeel N, Birkeland KI, Jenum AK (2015)
Ethnic differences in postpartum weight retention: a Norwegian cohort study
BJOG, 123 (5), 699-708
DOI 10.1111/1471-0528.13321, PubMed 25716276

Publications 2014

Birkeland KI (2014)
[How is the quality of the diabetes care?]
Tidsskr Nor Laegeforen, 134 (2), 133
DOI 10.4045/tidsskr.13.1435, PubMed 24477123

Bordeleau L, Yakubovich N, Dagenais GR, Rosenstock J, Probstfield J, Chang Yu P, Ryden LE, Pirags V, Spinas GA, Birkeland KI, Ratner RE, Marin-Neto JA, Keltai M, Riddle MC, Bosch J, Yusuf S, Gerstein HC, ORIGIN Trial Investigators (2014)
The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia
Diabetes Care, 37 (5), 1360-6
DOI 10.2337/dc13-1468, PubMed 24574355

Gulseth HL, Risstad H, Birkeland KI (2014)
Bariatric surgery versus intensive medical therapy for diabetes
N Engl J Med, 371 (7), 681
DOI 10.1056/NEJMc1407393, PubMed 25119618

Li Y, Lee S, Langleite T, Norheim F, Pourteymour S, Jensen J, Stadheim HK, Storås TH, Davanger S, Gulseth HL, Birkeland KI, Drevon CA, Holen T (2014)
Subsarcolemmal lipid droplet responses to a combined endurance and strength exercise intervention
Physiol Rep, 2 (11)
DOI 10.14814/phy2.12187, PubMed 25413318

Mørkrid K, Jenum AK, Berntsen S, Sletner L, Richardsen KR, Vangen S, Holme I, Birkeland KI (2014)
Objectively recorded physical activity and the association with gestational diabetes
Scand J Med Sci Sports, 24 (5), e389-97
DOI 10.1111/sms.12183, PubMed 24894027

Norheim F, Hjorth M, Langleite TM, Lee S, Holen T, Bindesbøll C, Stadheim HK, Gulseth HL, Birkeland KI, Kielland A, Jensen J, Dalen KT, Drevon CA (2014)
Regulation of angiopoietin-like protein 4 production during and after exercise
Physiol Rep, 2 (8)
DOI 10.14814/phy2.12109, PubMed 25138789

Ofstad AP, Johansen OE, Gullestad L, Birkeland KI, Orvik E, Fagerland MW, Urheim S, Aakhus S (2014)
Neutral impact on systolic and diastolic cardiac function of 2 years of intensified multi-intervention in type 2 diabetes: the randomized controlled Asker and Bærum Cardiovascular Diabetes (ABCD) study
Am Heart J, 168 (3), 280-288.e2
DOI 10.1016/j.ahj.2014.03.026, PubMed 25173538

Sachse D, Bærug A, Sletner L, Birkeland KI, Nakstad B, Jenum AK, Berg JP (2014)
Urine NMR metabolomics analysis of breastfeeding biomarkers during and after pregnancy in a large prospective cohort study
Scand J Clin Lab Invest, 74 (3), 264-72
DOI 10.3109/00365513.2014.884240, PubMed 24621206

Sletner L, Jenum AK, Mørkrid K, Vangen S, Holme IM, Birkeland KI, Nakstad B (2014)
Maternal life course socio-economic position and offspring body composition at birth in a multi-ethnic population
Paediatr Perinat Epidemiol, 28 (5), 445-54
DOI 10.1111/ppe.12137, PubMed 25060595

Strøm H, Selmer R, Birkeland KI, Schirmer H, Berg TJ, Jenum AK, Midthjell K, Berg C, Stene LC (2014)
No increase in new users of blood glucose-lowering drugs in Norway 2006-2011: a nationwide prescription database study
BMC Public Health, 14, 520
DOI 10.1186/1471-2458-14-520, PubMed 24886413

Wium C, Eggesbø HB, Ueland T, Michelsen AE, Torjesen PA, Aukrust P, Birkeland K (2014)
Adipose tissue distribution in relation to insulin sensitivity and inflammation in Pakistani and Norwegian subjects with type 2 diabetes
Scand J Clin Lab Invest, 74 (8), 700-7
DOI 10.3109/00365513.2014.953571, PubMed 25223599

Publications 2013

Gulseth HL, Gjelstad IM, Birkeland KI, Drevon CA (2013)
Vitamin D and the metabolic syndrome
Curr Vasc Pharmacol, 11 (6), 968-84
DOI 10.2174/15701611113119990169, PubMed 24168438

Meneghini L, Atkin SL, Gough SC, Raz I, Blonde L, Shestakova M, Bain S, Johansen T, Begtrup K, Birkeland KI, NN1250-3668 (BEGIN FLEX) Trial Investigators (2013)
The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: a 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes
Diabetes Care, 36 (4), 858-64
DOI 10.2337/dc12-1668, PubMed 23340894

Norheim F, Langleite TM, Hjorth M, Holen T, Kielland A, Stadheim HK, Gulseth HL, Birkeland KI, Jensen J, Drevon CA (2013)
The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans
FEBS J, 281 (3), 739-49
DOI 10.1111/febs.12619, PubMed 24237962

Ofstad AP, Gullestad L, Orvik E, Aakhus S, Endresen K, Ueland T, Aukrust P, Fagerland MW, Birkeland KI, Johansen OE (2013)
Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort study
Cardiovasc Diabetol, 12, 126
DOI 10.1186/1475-2840-12-126, PubMed 23987834

Sletner L, Nakstad B, Yajnik CS, Mørkrid K, Vangen S, Vårdal MH, Holme IM, Birkeland KI, Jenum AK (2013)
Ethnic differences in neonatal body composition in a multi-ethnic population and the impact of parental factors: a population-based cohort study
PLoS One, 8 (8), e73058
DOI 10.1371/journal.pone.0073058, PubMed 24009731

Sommer C, Mørkrid K, Jenum AK, Sletner L, Mosdøl A, Birkeland KI (2013)
Weight gain, total fat gain and regional fat gain during pregnancy and the association with gestational diabetes: a population-based cohort study
Int J Obes (Lond), 38 (1), 76-81
DOI 10.1038/ijo.2013.185, PubMed 24051503

Sommer C, Sletner L, Jenum AK, Mørkrid K, Andersen LF, Birkeland KI, Mosdøl A (2013)
Ethnic differences in maternal dietary patterns are largely explained by socio-economic score and integration score: a population-based study
Food Nutr Res, 57
DOI 10.3402/fnr.v57i0.21164, PubMed 23843779

Tran AT, Straand J, Dalen I, Birkeland KI, Claudi T, Cooper JG, Meyer HE, Jenum AK (2013)
Pharmacological primary and secondary cardiovascular prevention among diabetic patients in a multiethnic general practice population: still room for improvements
BMC Health Serv Res, 13, 182
DOI 10.1186/1472-6963-13-182, PubMed 23688317

Wium C, Gulseth HL, Eriksen EF, Birkeland KI (2013)
Characteristics of glucose metabolism in Nordic and South Asian subjects with type 2 diabetes
PLoS One, 8 (12), e83983
DOI 10.1371/journal.pone.0083983, PubMed 24391858

Wium C, Aasheim ET, Ueland T, Michelsen AE, Thorsby PM, Larsen IF, Torjesen PA, Aukrust P, Birkeland KI (2013)
Differences in insulin sensitivity, lipid metabolism and inflammation between young adult Pakistani and Norwegian patients with type 2 diabetes: a cross sectional study
BMC Endocr Disord, 13, 49
DOI 10.1186/1472-6823-13-49, PubMed 24148878

Publications 2012

Berntsen S, Richardsen KR, Mørkrid K, Sletner L, Birkeland KI, Jenum AK (2012)
Objectively recorded physical activity in early pregnancy: a multiethnic population-based study
Scand J Med Sci Sports, 24 (3), 594-601
DOI 10.1111/sms.12034, PubMed 23278771

Birkeland KI (2012)
[Early insulin therapy in type 2 diabetes?]
Tidsskr Nor Laegeforen, 132 (19), 2151-2
DOI 10.4045/tidsskr.12.0866, PubMed 23076480

Home PD, Meneghini L, Wendisch U, Ratner RE, Johansen T, Christensen TE, Jendle J, Roberts AP, Birkeland KI (2012)
Improved health status with insulin degludec compared with insulin glargine in people with type 1 diabetes
Diabet Med, 29 (6), 716-20
DOI 10.1111/j.1464-5491.2011.03547.x, PubMed 22150786

Jenum AK, Diep LM, Holmboe-Ottesen G, Holme IM, Kumar BN, Birkeland KI (2012)
Diabetes susceptibility in ethnic minority groups from Turkey, Vietnam, Sri Lanka and Pakistan compared with Norwegians - the association with adiposity is strongest for ethnic minority women
BMC Public Health, 12, 150
DOI 10.1186/1471-2458-12-150, PubMed 22380873

Mørkrid K, Jenum AK, Sletner L, Vårdal MH, Waage CW, Nakstad B, Vangen S, Birkeland KI (2012)
Failure to increase insulin secretory capacity during pregnancy-induced insulin resistance is associated with ethnicity and gestational diabetes
Eur J Endocrinol, 167 (4), 579-88
DOI 10.1530/EJE-12-0452, PubMed 22889687

Sachse D, Sletner L, Mørkrid K, Jenum AK, Birkeland KI, Rise F, Piehler AP, Berg JP (2012)
Metabolic changes in urine during and after pregnancy in a large, multiethnic population-based cohort study of gestational diabetes
PLoS One, 7 (12), e52399
DOI 10.1371/journal.pone.0052399, PubMed 23285025

Telle-Hjellset V, Råberg Kjøllesdal MK, Bjørge B, Holmboe-Ottesen G, Wandel M, Birkeland KI, Eriksen HR, Høstmark AT (2012)
The InnvaDiab-DE-PLAN study: a randomised controlled trial with a culturally adapted education programme improved the risk profile for type 2 diabetes in Pakistani immigrant women
Br J Nutr, 109 (3), 529-38
DOI 10.1017/S000711451200133X, PubMed 22717286

Ueland T, Aukrust P, Aakhus S, Smith C, Endresen K, Birkeland KI, Gullestad L, Johansen OE (2012)
Activin A and cardiovascular disease in type 2 diabetes mellitus
Diab Vasc Dis Res, 9 (3), 234-7
DOI 10.1177/1479164111431171, PubMed 22234949

Publications 2011

Birkeland KI, Home PD, Wendisch U, Ratner RE, Johansen T, Endahl LA, Lyby K, Jendle JH, Roberts AP, DeVries JH, Meneghini LF (2011)
Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine
Diabetes Care, 34 (3), 661-5
DOI 10.2337/dc10-1925, PubMed 21270174

Gjelstad IM, Haugen F, Gulseth HL, Norheim F, Jans A, Bakke SS, Raastad T, Tjønna AE, Wisløff U, Blaak EE, Risérus U, Gaster M, Roche HM, Birkeland KI, Drevon CA (2011)
Expression of perilipins in human skeletal muscle in vitro and in vivo in relation to diet, exercise and energy balance
Arch Physiol Biochem, 118 (1), 22-30
DOI 10.3109/13813455.2011.630009, PubMed 22117101

Haukeland JW, Dahl TB, Yndestad A, Gladhaug IP, Løberg EM, Haaland T, Konopski Z, Wium C, Aasheim ET, Johansen OE, Aukrust P, Halvorsen B, Birkeland KI (2011)
Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies
Eur J Endocrinol, 166 (3), 503-10
DOI 10.1530/EJE-11-0864, PubMed 22170794

Jenum AK, Mørkrid K, Sletner L, Vangen S, Torper JL, Nakstad B, Voldner N, Rognerud-Jensen OH, Berntsen S, Mosdøl A, Skrivarhaug T, Vårdal MH, Holme I, Yajnik CS, Birkeland KI (2011)
Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study
Eur J Endocrinol, 166 (2), 317-24
DOI 10.1530/EJE-11-0866, PubMed 22108914

Søvik TT, Aasheim ET, Taha O, Engström M, Fagerland MW, Björkman S, Kristinsson J, Birkeland KI, Mala T, Olbers T (2011)
Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial
Ann Intern Med, 155 (5), 281-91
DOI 10.7326/0003-4819-155-5-201109060-00005, PubMed 21893621

Tran AT, Straand J, Diep LM, Meyer HE, Birkeland KI, Jenum AK (2011)
Cardiovascular disease by diabetes status in five ethnic minority groups compared to ethnic Norwegians
BMC Public Health, 11, 554
DOI 10.1186/1471-2458-11-554, PubMed 21752237

Aasheim ET, Elshorbagy AK, Diep LM, Søvik TT, Mala T, Valdivia-Garcia M, Olbers T, Bøhmer T, Birkeland KI, Refsum H (2011)
Effect of bariatric surgery on sulphur amino acids and glutamate
Br J Nutr, 106 (3), 432-40
DOI 10.1017/S0007114511000201, PubMed 21554803

Publications 2010

Atar D, Birkeland KI, Uhlig T (2010)
'Treat to target': moving targets from hypertension, hyperlipidaemia and diabetes to rheumatoid arthritis
Ann Rheum Dis, 69 (4), 629-30
DOI 10.1136/ard.2010.128462, PubMed 20237122

Birkeland KI (2010)
[Metabolic and cardiovascular health in mental disorders]
Tidsskr Nor Laegeforen, 130 (3), 285-6
DOI 10.4045/tidsskr.09.1194, PubMed 20160775

Charbonnel B, DeFronzo R, Davidson J, Schmitz O, Birkeland K, Pirags V, Scheen A, PROactive investigators (2010)
Pioglitazone use in combination with insulin in the prospective pioglitazone clinical trial in macrovascular events study (PROactive19)
J Clin Endocrinol Metab, 95 (5), 2163-71
DOI 10.1210/jc.2009-1974, PubMed 20237169

Dahl TB, Haukeland JW, Yndestad A, Ranheim T, Gladhaug IP, Damås JK, Haaland T, Løberg EM, Arntsen B, Birkeland K, Bjøro K, Ulven SM, Konopski Z, Nebb HI, Aukrust P, Halvorsen B (2010)
Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease
J Clin Endocrinol Metab, 95 (6), 3039-47
DOI 10.1210/jc.2009-2148, PubMed 20392873

Gulseth HL, Gjelstad IM, Tierney AC, Lovegrove JA, Defoort C, Blaak EE, Lopez-Miranda J, Kiec-Wilk B, Risérus U, Roche HM, Drevon CA, Birkeland KI (2010)
Serum vitamin D concentration does not predict insulin action or secretion in European subjects with the metabolic syndrome
Diabetes Care, 33 (4), 923-5
DOI 10.2337/dc09-1692, PubMed 20067973

Gulseth HL, Gjelstad IM, Tierney AC, Shaw DI, Helal O, Hees AM, Delgado-Lista J, Leszczynska-Golabek I, Karlström B, Lovegrove J, Defoort C, Blaak EE, Lopez-Miranda J, Dembinska-Kiec A, Risérus U, Roche HM, Birkeland KI, Drevon CA (2010)
Dietary fat modifications and blood pressure in subjects with the metabolic syndrome in the LIPGENE dietary intervention study
Br J Nutr, 104 (2), 160-3
DOI 10.1017/S0007114510000565, PubMed 20202290

Hallén J, Johansen OE, Birkeland KI, Gullestad L, Aakhus S, Endresen K, Tjora S, Jaffe AS, Atar D (2010)
Determinants and prognostic implications of cardiac troponin T measured by a sensitive assay in type 2 diabetes mellitus
Cardiovasc Diabetol, 9, 52
DOI 10.1186/1475-2840-9-52, PubMed 20843304

Jenum AK, Sletner L, Voldner N, Vangen S, Mørkrid K, Andersen LF, Nakstad B, Skrivarhaug T, Rognerud-Jensen OH, Roald B, Birkeland KI (2010)
The STORK Groruddalen research programme: A population-based cohort study of gestational diabetes, physical activity, and obesity in pregnancy in a multiethnic population. Rationale, methods, study population, and participation rates
Scand J Public Health, 38 (5 Suppl), 60-70
DOI 10.1177/1403494810378921, PubMed 21062840

Solaas K, Legry V, Retterstol K, Berg PR, Holven KB, Ferrières J, Amouyel P, Lien S, Romeo J, Valtueña J, Widhalm K, Ruiz JR, Dallongeville J, Tonstad S, Rootwelt H, Halvorsen B, Nenseter MS, Birkeland KI, Thorsby PM, Meirhaeghe A, Nebb HI (2010)
Suggestive evidence of associations between liver X receptor β polymorphisms with type 2 diabetes mellitus and obesity in three cohort studies: HUNT2 (Norway), MONICA (France) and HELENA (Europe)
BMC Med Genet, 11, 144
DOI 10.1186/1471-2350-11-144, PubMed 20939869

Søvik TT, Irandoust B, Birkeland KI, Aasheim ET, Schou CF, Kristinsson J, Mala T (2010)
[Type 2 diabetes and metabolic syndrome before and after gastric bypass]
Tidsskr Nor Laegeforen, 130 (13), 1347-50
DOI 10.4045/tidsskr.09.0935, PubMed 20596116

Tran AT, Diep LM, Cooper JG, Claudi T, Straand J, Birkeland K, Ingskog W, Jenum AK (2010)
Quality of care for patients with type 2 diabetes in general practice according to patients' ethnic background: a cross-sectional study from Oslo, Norway
BMC Health Serv Res, 10, 145
DOI 10.1186/1472-6963-10-145, PubMed 20507647

Publications 2009

Birkenaes AB, Birkeland KI, Friis S, Opjordsmoen S, Andreassen OA (2009)
Hormonal markers of metabolic dysregulation in patients with severe mental disorders after olanzapine treatment under real-life conditions
J Clin Psychopharmacol, 29 (2), 109-16
DOI 10.1097/JCP.0b013e31819b95fc, PubMed 19512971

Haukeland JW, Konopski Z, Eggesbø HB, von Volkmann HL, Raschpichler G, Bjøro K, Haaland T, Løberg EM, Birkeland K (2009)
Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial
Scand J Gastroenterol, 44 (7), 853-60
DOI 10.1080/00365520902845268, PubMed 19811343

Johansen OE, Birkeland KI, Jørgensen AP, Orvik E, Sørgård B, Torjussen BR, Ueland T, Aukrust P, Gullestad L (2009)
Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trial
J Diabetes, 1 (3), 182-7
DOI 10.1111/j.1753-0407.2009.00031.x, PubMed 20923537

Parhofer KG, Birkeland KI, DeFronzo R, Del Prato S, Bhaumik A, Ptaszynska A (2009)
Irbesartan has no short-term effect on insulin resistance in hypertensive patients with additional cardiometabolic risk factors (i-RESPOND)
Int J Clin Pract, 64 (2), 160-8
DOI 10.1111/j.1742-1241.2009.02246.x, PubMed 19929980

Scheen AJ, Tan MH, Betteridge DJ, Birkeland K, Schmitz O, Charbonnel B, PROactive investigators (2009)
Long-term glycaemic effects of pioglitazone compared with placebo as add-on treatment to metformin or sulphonylurea monotherapy in PROactive (PROactive 18)
Diabet Med, 26 (12), 1242-9
DOI 10.1111/j.1464-5491.2009.02857.x, PubMed 20002476

Thorsby PM, Midthjell K, Gjerlaugsen N, Holmen J, Hanssen KF, Birkeland KI, Berg JP (2009)
Comparison of genetic risk in three candidate genes (TCF7L2, PPARG, KCNJ11) with traditional risk factors for type 2 diabetes in a population-based study--the HUNT study
Scand J Clin Lab Invest, 69 (2), 282-7
DOI 10.1080/00365510802538188, PubMed 18972257

Yndestad A, Haukeland JW, Dahl TB, Bjøro K, Gladhaug IP, Berge C, Damås JK, Haaland T, Løberg EM, Linnestad P, Birkeland K, Konopski Z, Halvorsen B, Berge RK, Aukrust P (2009)
A complex role of activin A in non-alcoholic fatty liver disease
Am J Gastroenterol, 104 (9), 2196-205
DOI 10.1038/ajg.2009.318, PubMed 19532130

Aas AM, Hanssen KF, Berg JP, Thorsby PM, Birkeland KI (2009)
Insulin-stimulated increase in serum leptin levels precedes and correlates with weight gain during insulin therapy in type 2 diabetes
J Clin Endocrinol Metab, 94 (8), 2900-6
DOI 10.1210/jc.2008-1005, PubMed 19509109

Aas AM, Ohrvik J, Malmberg K, Rydén L, Birkeland KI, DIGAMI 2 Investigators (2009)
Insulin-induced weight gain and cardiovascular events in patients with type 2 diabetes. A report from the DIGAMI 2 study
Diabetes Obes Metab, 11 (4), 323-9
DOI 10.1111/j.1463-1326.2008.00964.x, PubMed 19267710

Aasheim ET, Frigstad SO, Søvik TT, Birkeland KI, Haukeland JW (2009)
Hyperinsulinemic hypoglycemia and liver cirrhosis presenting after duodenal switch: a case report
Surg Obes Relat Dis, 6 (4), 441-3
DOI 10.1016/j.soard.2009.11.007, PubMed 20096646

Publications 2008

Birkeland KI (2008)
[Overweight in diabetes--what is the best treatment?]
Tidsskr Nor Laegeforen, 128 (4), 445-6
PubMed 18309536

Birkenaes AB, Birkeland KI, Engh JA, Faerden A, Jonsdottir H, Ringen PA, Friis S, Opjordsmoen S, Andreassen OA (2008)
Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions
J Clin Psychopharmacol, 28 (2), 132-7
DOI 10.1097/JCP.0b013e318166c4f7, PubMed 18344722

Kase ET, Birkeland KI (2008)
[Antidiabetics which affect the incretin system]
Tidsskr Nor Laegeforen, 128 (4), 440-2
PubMed 18274578

Ribu L, Birkeland K, Hanestad BR, Moum T, Rustoen T (2008)
A longitudinal study of patients with diabetes and foot ulcers and their health-related quality of life: wound healing and quality-of-life changes
J Diabetes Complications, 22 (6), 400-7
DOI 10.1016/j.jdiacomp.2007.06.006, PubMed 18413188

Aasheim ET, Hofsø D, Hjelmesaeth J, Birkeland KI, Bøhmer T (2008)
Vitamin status in morbidly obese patients: a cross-sectional study
Am J Clin Nutr, 87 (2), 362-9
DOI 10.1093/ajcn/87.2.362, PubMed 18258626

Publications 2007

Birkenaes AB, Opjordsmoen S, Brunborg C, Engh JA, Jonsdottir H, Ringen PA, Simonsen C, Vaskinn A, Birkeland KI, Friis S, Sundet K, Andreassen OA (2007)
The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study
J Clin Psychiatry, 68 (6), 917-23
DOI 10.4088/jcp.v68n0614, PubMed 17592917

Johansen OE, Birkeland KI (2007)
Defining the role of repaglinide in the management of type 2 diabetes mellitus: a review
Am J Cardiovasc Drugs, 7 (5), 319-35
DOI 10.2165/00129784-200707050-00002, PubMed 17953471

Johansen OE, Birkeland KI, Orvik E, Flesland Ø, Wergeland R, Ueland T, Smith C, Endresen K, Aukrust P, Gullestad L (2007)
Inflammation and coronary angiography in asymptomatic type 2 diabetic subjects
Scand J Clin Lab Invest, 67 (3), 306-16
DOI 10.1080/00365510601045088, PubMed 17454845

Johansen OE, Bjurö T, Endresen K, Blaasaas KG, Birkeland K, Aakhus S, Gullestad L (2007)
Heart rate adjustments and analysis of recovery patterns of ST-segment depression in type 2 diabetes
Int J Cardiol, 127 (1), 129-32
DOI 10.1016/j.ijcard.2007.04.022, PubMed 17532067

Johansen OE, Gullestad L, Blaasaas KG, Orvik E, Birkeland KI (2007)
Effects of structured hospital-based care compared with standard care for Type 2 diabetes-The Asker and Baerum Cardiovascular Diabetes Study, a randomized trial
Diabet Med, 24 (9), 1019-27
DOI 10.1111/j.1464-5491.2007.02198.x, PubMed 17509068

Ribu L, Hanestad BR, Moum T, Birkeland K, Rustoen T (2007)
Health-related quality of life among patients with diabetes and foot ulcers: association with demographic and clinical characteristics
J Diabetes Complications, 21 (4), 227-36
DOI 10.1016/j.jdiacomp.2007.02.001, PubMed 17616352

Publications 2006

Bergersen BM, Schumacher A, Sandvik L, Bruun JN, Birkeland K (2006)
Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controls
Scand J Infect Dis, 38 (8), 682-9
DOI 10.1080/00365540500361302, PubMed 16857615

Birkeland KI (2006)
[Insulin treatment of type 1 diabetes in adults]
Tidsskr Nor Laegeforen, 126 (6), 776-8
PubMed 16541173

Birkeland KI (2006)
[Insulin treatment in type 2 diabetes]
Tidsskr Nor Laegeforen, 126 (7), 919-20
PubMed 16554885

Birkeland KI (2006)
[Clinical use of long-acting insulin analogs]
Tidsskr Nor Laegeforen, 126 (8), 1067-8
PubMed 16619068

Gustafsson I, Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt PR, MacLeod K, Laakso M, Torp-Pedersen CT, Waldenström A, DIGAMI-2 investigatorerne (2006)
[Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication]
Ugeskr Laeger, 168 (6), 581-4
PubMed 16476220

Haukeland JW, Damås JK, Konopski Z, Løberg EM, Haaland T, Goverud I, Torjesen PA, Birkeland K, Bjøro K, Aukrust P (2006)
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
J Hepatol, 44 (6), 1167-74
DOI 10.1016/j.jhep.2006.02.011, PubMed 16618517

Jenum AK, Anderssen SA, Birkeland KI, Holme I, Graff-Iversen S, Lorentzen C, Ommundsen Y, Raastad T, Odegaard AK, Bahr R (2006)
Promoting physical activity in a low-income multiethnic district: effects of a community intervention study to reduce risk factors for type 2 diabetes and cardiovascular disease: a community intervention reducing inactivity
Diabetes Care, 29 (7), 1605-12
DOI 10.2337/dc05-1587, PubMed 16801586

Johansen OE, Birkeland KI, Brustad E, Aaser E, Lindahl AK, Midha R, Ueland T, Aukrust P, Gullestad L (2006)
Undiagnosed dysglycaemia and inflammation in cardiovascular disease
Eur J Clin Invest, 36 (8), 544-51
DOI 10.1111/j.1365-2362.2006.01679.x, PubMed 16893376

Ribu L, Hanestad BR, Moum T, Birkeland K, Rustoen T (2006)
A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a nondiabetes group from the general population
Qual Life Res, 16 (2), 179-89
DOI 10.1007/s11136-006-0031-y, PubMed 17091370

Ribu L, Rustøen T, Birkeland K, Hanestad BR, Paul SM, Miaskowski C (2006)
The prevalence and occurrence of diabetic foot ulcer pain and its impact on health-related quality of life
J Pain, 7 (4), 290-9
DOI 10.1016/j.jpain.2005.12.002, PubMed 16618473

Aas AM, Seljeflot I, Torjesen PA, Diep LM, Thorsby PM, Birkeland KI (2006)
Blood glucose lowering by means of lifestyle intervention has different effects on adipokines as compared with insulin treatment in subjects with type 2 diabetes
Diabetologia, 49 (5), 872-80
DOI 10.1007/s00125-006-0205-8, PubMed 16555056

Publications 2005

Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefèbvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Korányi L, Laakso M, Mokán M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W et al. (2005)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
Lancet, 366 (9493), 1279-89
DOI 10.1016/S0140-6736(05)67528-9, PubMed 16214598

Haukeland JW, Konopski Z, Linnestad P, Azimy S, Marit Løberg E, Haaland T, Birkeland K, Bjøro K (2005)
Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease
Scand J Gastroenterol, 40 (12), 1469-77
DOI 10.1080/00365520500264953, PubMed 16293559

Hjeltnes N, De Groot P, Birkeland KI, Falch JA, Iversen PO (2005)
Tetraplegic subjects have hyperleptinaemia with marked circadian variation
Clin Endocrinol (Oxf), 62 (2), 223-7
DOI 10.1111/j.1365-2265.2005.02204.x, PubMed 15670200

Jenum AK, Holme I, Graff-Iversen S, Birkeland KI (2005)
Ethnicity and sex are strong determinants of diabetes in an urban Western society: implications for prevention
Diabetologia, 48 (3), 435-9
DOI 10.1007/s00125-005-1668-8, PubMed 15729578

Johansen OE, Birkeland KI (2005)
[Misleading about insulin administration to patients with diabetes]
Tidsskr Nor Laegeforen, 125 (16), 2247; author reply 2247
PubMed 16138161

Kilhovd BK, Juutilainen A, Lehto S, Rönnemaa T, Torjesen PA, Birkeland KI, Berg TJ, Hanssen KF, Laakso M (2005)
High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men: a population-based 18-year follow-up study
Arterioscler Thromb Vasc Biol, 25 (4), 815-20
DOI 10.1161/01.ATV.0000158380.44231.fe, PubMed 15692098

Os I, Os A, Abdelnoor M, Larsen A, Birkeland K, Westheim A (2005)
Insulin sensitivity in women with coronary heart disease during hormone replacement therapy
J Womens Health (Larchmt), 14 (2), 137-45
DOI 10.1089/jwh.2005.14.137, PubMed 15775731

Thorsby PM, Berg JP, Birkeland KI (2005)
Insulin gene variable number of tandem repeats is associated with increased fat mass during adolescence in non-obese girls
Scand J Clin Lab Invest, 65 (2), 163-8
DOI 10.1080/00365510510013622, PubMed 16025839

Aas AM, Bergstad I, Thorsby PM, Johannesen O, Solberg M, Birkeland KI (2005)
An intensified lifestyle intervention programme may be superior to insulin treatment in poorly controlled Type 2 diabetic patients on oral hypoglycaemic agents: results of a feasibility study
Diabet Med, 22 (3), 316-22
DOI 10.1111/j.1464-5491.2005.01421.x, PubMed 15717881

Publications 2004

Kølendorf K, Eriksson J, Birkeland KI, Kjellström T, Hreidarsson AB (2004)
Dose titration of repaglinide in patients with inadequately controlled type 2 diabetes
Diabetes Res Clin Pract, 64 (1), 33-40
DOI 10.1016/j.diabres.2003.10.006, PubMed 15036825

Nissen-Lie G, Birkeland K, Hemmersbach P, Skibeli V (2004)
Serum sTfR levels may indicate charge profiling of urinary r-hEPO in doping control
Med Sci Sports Exerc, 36 (4), 588-93
DOI 10.1249/01.mss.0000121953.90379.a7, PubMed 15064585

Stene LC, Midthjell K, Jenum AK, Skeie S, Birkeland KI, Lund E, Joner G, Tell GS, Schirmer H (2004)
[Prevalence of diabetes mellitus in Norway]
Tidsskr Nor Laegeforen, 124 (11), 1511-4
PubMed 15195154

Veitenhansl M, Stegner K, Hierl FX, Dieterle C, Feldmeier H, Gutt B, Landgraf R, Garrow AP, Vileikyte L, Findlow A, Waterman C, Boulton AJ, Shankhdhar K, Shankhdhar L, Shankhdhar U, Petrova NL, Foster AV, Edmonds ME, Ferraresi R, Caravaggi C, De Giglio R, Cavaiani P, Pogliaghi I, Sommariva E, Katz IA et al. (2004)
40th EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004
Diabetologia, 47 (Suppl 1), A1-A464
DOI 10.1007/BF03375463, PubMed 27770180

Publications 2003

Abebe F, Birkeland KI, Gaarder PI, Petros B, Gundersen SG (2003)
The relationships between dehydroepiandrosterone sulphate (DHEAS), the intensity of Schistosoma mansoni infection and parasite-specific antibody responses. A cross-sectional study in residents of endemic communities in north-east Ethiopia
APMIS, 111 (2), 319-28
DOI 10.1034/j.1600-0463.2003.1110205.x, PubMed 12716389

Birkeland KI, Kilhovd B, Thorsby P, Torjesen PA, Ganss R, Vaaler S, Hanssen KF (2003)
Heterogeneity of non-insulin-dependent diabetes expressed as variability in insulin sensitivity, beta-cell function and cardiovascular risk profile
Diabet Med, 20 (1), 37-45
DOI 10.1046/j.1464-5491.2003.00838.x, PubMed 12519318

Bleskestad IH, Birkeland KI (2003)
[Differences between oral antidiabetics]
Tidsskr Nor Laegeforen, 123 (6), 808-9
PubMed 12693123

Claudi T, Birkeland K, Jensen T (2003)
[Statins and diabetes--indications and refusal rules]
Tidsskr Nor Laegeforen, 123 (11), 1564-5
PubMed 12822023

Johansen OE, Birkeland KI (2003)
Preventing macrovascular disease in patients with type 2 diabetes mellitus
Am J Cardiovasc Drugs, 3 (4), 283-97
DOI 10.2165/00129784-200303040-00007, PubMed 14728081

Karen Jenum A, Lorentzen C, Anderssen SA, Birkeland KI, Holme I, Lund-Larsen PG, Ommundsen Y, Raastad T, Thelle DS, Bahr R (2003)
Promoting physical activity in a multi-ethnic district - methods and baseline results of a pseudo-experimental intervention study
Eur J Cardiovasc Prev Rehabil, 10 (5), 387-96
DOI 10.1097/01.hjr.0000085244.65733.94, PubMed 14663301

Kilhovd BK, Giardino I, Torjesen PA, Birkeland KI, Berg TJ, Thornalley PJ, Brownlee M, Hanssen KF (2003)
Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes
Metabolism, 52 (2), 163-7
DOI 10.1053/meta.2003.50035, PubMed 12601626

Publications 2002

Birkeland KI (2002)
[Can diabetes be prevented?]
Tidsskr Nor Laegeforen, 122 (2), 155
PubMed 11873567

Publications 2001

Birkeland KI (2001)
[Glitazones--a new therapeutic principle in diabetes]
Tidsskr Nor Laegeforen, 121 (22), 2617-9
PubMed 11668762

Birkeland KI, Berg JP (2001)
Type 2 diabetes--preventable, but how?
Eur J Endocrinol, 145 (5), 573-5
DOI 10.1530/eje.0.1450573, PubMed 11720873

Publications 2000

Birkeland KI, Claudi T, Hansteen V, Hanssen KF, Hjermann I, Jenssen T, Jervell J, Os I (2000)
[Prevention of cardiovascular disease in type 2 diabetes]
Tidsskr Nor Laegeforen, 120 (21), 2554-9
PubMed 11070996

Birkeland KI, Stray-Gundersen J, Hemmersbach P, Hallen J, Haug E, Bahr R (2000)
Effect of rhEPO administration on serum levels of sTfR and cycling performance
Med Sci Sports Exerc, 32 (7), 1238-43
DOI 10.1097/00005768-200007000-00009, PubMed 10912888

Thorsby P, Kilhovd B, Sletmo R, Martinsen S, Birkeland KI (2000)
[Hypoglycemic treatment of type 2 diabetes]
Tidsskr Nor Laegeforen, 120 (20), 2434-40
PubMed 11475233

Tonstad S, Birkeland KI (2000)
[The obesity epidemics--do diet pills have a place in the treatment?]
Tidsskr Nor Laegeforen, 120 (17), 1997-2001
PubMed 11008533

Publications 1999

Birkeland KI, Hemmersbach P (1999)
The future of doping control in athletes. Issues related to blood sampling
Sports Med, 28 (1), 25-33
DOI 10.2165/00007256-199928010-00003, PubMed 10461710

Kilhovd BK, Berg TJ, Birkeland KI, Thorsby P, Hanssen KF (1999)
Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease
Diabetes Care, 22 (9), 1543-8
DOI 10.2337/diacare.22.9.1543, PubMed 10480523

Melander A, Olsson J, Lindberg G, Salzman A, Howard T, Stang P, Lydick E, Emslie-Smith A, Boyle DI, Evans JM, Macdonald TM, Bain J, Sullivan F, AD Morris for the DARTS/MEMO Collaboration, Juhl C, Pørksen N, Sturis J, Hollingdal M, Pincus S, Veldhuis J, Dejgaard A, Schmitz O, Kristensen JS, Frandsen KB, Bayer T et al. (1999)
35th Annual Meeting of the European Association for the Study of Diabetes : Brussels, Belgium, 28 September-2 October 1999
Diabetologia, 42 (Suppl 1), A1-A330
DOI 10.1007/BF03375458, PubMed 27770183

Publications 1998

Birkeland KI (1998)
Improving glycaemic control with current therapies
Diabet Med, 15 Suppl 4, S13-9
DOI 10.1002/(sici)1096-9136(1998120)15:4+3.3.co;2-e, PubMed 9868986

Hanssen KF, Birkeland KI, Thorsby P (1998)
[Type 2-diabetes consists of several diseases]
Tidsskr Nor Laegeforen, 118 (7), 1025
PubMed 9531820

Lorentzen B, Birkeland KI, Endresen MJ, Henriksen T (1998)
Glucose intolerance in women with preeclampsia
Acta Obstet Gynecol Scand, 77 (1), 22-7
DOI 10.1034/j.1600-0412.1998.770105.x, PubMed 9492712

Thorsby P, Undlien DE, Berg JP, Thorsby E, Birkeland KI (1998)
[Diabetes mellitus--a complex interaction between heredity and environment]
Tidsskr Nor Laegeforen, 118 (16), 2519-24
PubMed 9667132

Tomten SE, Falch JA, Birkeland KI, Hemmersbach P, Høstmark AT (1998)
Bone mineral density and menstrual irregularities. A comparative study on cortical and trabecular bone structures in runners with alleged normal eating behavior
Int J Sports Med, 19 (2), 92-7
DOI 10.1055/s-2007-971888, PubMed 9562216

Publications 1997

Birkeland KI, Donike M, Ljungqvist A, Fagerhol M, Jensen J, Hemmersbach P, Oftebro H, Haug E (1997)
Blood sampling in doping control. First experiences from regular testing in athletics
Int J Sports Med, 18 (1), 8-12
DOI 10.1055/s-2007-972587, PubMed 9059898

Hjeltnes N, Aksnes AK, Birkeland KI, Johansen J, Lannem A, Wallberg-Henriksson H (1997)
Improved body composition after 8 wk of electrically stimulated leg cycling in tetraplegic patients
Am J Physiol, 273 (3 Pt 2), R1072-9
DOI 10.1152/ajpregu.1997.273.3.R1072, PubMed 9321888

Toft I, Bønaa KH, Ingebretsen OC, Nordøy A, Birkeland KI, Jenssen T (1997)
Gender differences in the relationships between plasma plasminogen activator inhibitor-1 activity and factors linked to the insulin resistance syndrome in essential hypertension
Arterioscler Thromb Vasc Biol, 17 (3), 553-9
DOI 10.1161/01.atv.17.3.553, PubMed 9102176

Torjesen PA, Birkeland KI, Anderssen SA, Hjermann I, Holme I, Urdal P (1997)
Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial
Diabetes Care, 20 (1), 26-31
DOI 10.2337/diacare.20.1.26, PubMed 9028689

Publications 1996

Birkeland KI, Rishaug U, Hanssen KF, Vaaler S (1996)
NIDDM: a rapid progressive disease. Results from a long-term, randomised, comparative study of insulin or sulphonylurea treatment
Diabetologia, 39 (12), 1629-33
DOI 10.1007/s001250050626, PubMed 8960854

Birkeland KI, Vaaler S, Hanssen KF (1996)
[Insulin treatment is of value--also in type 2 diabetes]
Tidsskr Nor Laegeforen, 116 (10), 1233-5
PubMed 8658397

Haug E, Birkeland KI, Hemmersbach P (1996)
[Doping legislation]
Tidsskr Nor Laegeforen, 116 (2), 297-8
PubMed 8633342

Publications 1995

Birkeland KI, Hanssen KF, Stranden E, Falch JA, Vaaler S (1995)
Insulin-mediated increase in calf blood flow is not related to blood pressure levels in patients with type 2 diabetes mellitus
Blood Press, 4 (2), 80-4
PubMed 7599758

Norli HR, Esbensen K, Westad F, Birkeland KI, Hemmersbach P (1995)
Chemometric evaluation of urinary steroid profiles in doping control
J Steroid Biochem Mol Biol, 54 (1-2), 83-8
DOI 10.1016/0960-0760(95)00114-f, PubMed 7632620

Rishaug U, Birkeland KI, Falch JA, Vaaler S (1995)
Bone mass in non-insulin-dependent diabetes mellitus
Scand J Clin Lab Invest, 55 (3), 257-62
DOI 10.3109/00365519509089621, PubMed 7638560

Samdal F, Birkeland KI, Ose L, Amland PF (1995)
Effect of large-volume liposuction on sex hormones and glucose- and lipid metabolism in females
Aesthetic Plast Surg, 19 (2), 131-5
PubMed 7598023

Publications 1994

Birkeland KI, Furuseth K, Melander A, Mowinckel P, Vaaler S (1994)
Long-term randomized placebo-controlled double-blind therapeutic comparison of glipizide and glyburide. Glycemic control and insulin secretion during 15 months
Diabetes Care, 17 (1), 45-9
DOI 10.2337/diacare.17.1.45, PubMed 8112188

Birkeland KI, Hanssen KF, Urdal P, Berg K, Vaaler S (1994)
A long-term, randomized, comparative study of insulin versus sulfonylurea therapy in type 2 diabetes
J Intern Med, 236 (3), 305-13
DOI 10.1111/j.1365-2796.1994.tb00801.x, PubMed 8077888

Birkeland KI, Jørgensen J, Hemmersbach P (1994)
[Endocrine effects of doping with androgenic anabolic steroids]
Tidsskr Nor Laegeforen, 114 (4), 426-8
PubMed 8009475

Birkeland KI, Torjesen PA, Eriksson J, Vaaler S, Groop L (1994)
Hyperproinsulinemia of type II diabetes is not present before the development of hyperglycemia
Diabetes Care, 17 (11), 1307-10
DOI 10.2337/diacare.17.11.1307, PubMed 7821172

Moan A, Nordby G, Os I, Birkeland KI, Kjeldsen SE (1994)
Relationship between hemorrheologic factors and insulin sensitivity in healthy young men
Metabolism, 43 (4), 423-7
DOI 10.1016/0026-0495(94)90070-1, PubMed 8159097

Publications 1993

Birkeland KI, Hanssen KF, Torjesen PA, Vaaler S (1993)
Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes
J Clin Endocrinol Metab, 76 (2), 275-8
DOI 10.1210/jcem.76.2.8432768, PubMed 8432768

Samdal F, Amland PF, Sandsmark M, Birkeland KI (1993)
Diabetic lipohypertrophy treated with suction-assisted lipectomy
J Intern Med, 234 (5), 489-92
DOI 10.1111/j.1365-2796.1993.tb00782.x, PubMed 8228793

Publications 1992

Birkeland KI, Chatzipanagiotou F, Hanssen KF, Vaaler S (1992)
Relationship between blood pressure and in vivo action of insulin in type II (non-insulin-dependent) diabetic subjects
Metabolism, 41 (3), 301-5
DOI 10.1016/0026-0495(92)90275-f, PubMed 1542270

Birkeland KI, Gallefoss F, Olsson S, Haug E (1992)
Primary hyperparathyroidism or hypercalcaemia of malignancy?
Scand J Clin Lab Invest, 52 (4), 347-9
DOI 10.1080/00365519209088368, PubMed 1439519

Publications 1991

Birkeland KI, Falch JA, Gautvik KM, Gjestvang FT, Holst N, Haug E (1991)
[Determination of intact parathyroid hormone in patients with calcium metabolism disorders]
Tidsskr Nor Laegeforen, 111 (15), 1840-4
PubMed 1853314

Birkeland KI, Gullestad L, Torsvik H (1991)
[Cholesterol-lowering effect of oat]
Tidsskr Nor Laegeforen, 111 (17), 2081-5
PubMed 1871737

Page visits: 7018